Горина А. А., Горбань Н. А., Гриневич В. Н.

Медицинский радиологический научный центр им. А. Ф. Цыба – филиал ФГБУ «Национальный медицинский исследовательский центр радиологии» Минздрава России; Россия, Калужская область, 249036 Обнинск, ул. Королева, 4

1. Matias-Guiu X., Selinger C.I., Anderson L. et al. Data set for the reporting of endometrial cancer: recommendations from the international collaboration on cancer reporting (ICCR). Int J Gynecol Pathol 2022;41(Suppl 1):90–118. DOI: 10.1097/PGP.0000000000000901

2. Peters E.E.M., Nucci M.R., Gilks C.B. et al. Practical guidance for assessing and reporting lymphovascular space invasion (LVSI) in endometrial carcinoma. Histopathology 2025;86:173–82. DOI: 10.1111/his.15272

3. Feng J., Zhang Y., Huang C. et al. Prognostic evaluation of lymph-vascular space invasion in patients with endometrioid and non-endometrioid endometrial cancer: A multicenter study. Eur J Surg Oncol 2024;50(4):108261. DOI: 10.1016/j.ejso.2024.108261

4. Нечушкина В.М., Коломиец Л.А., Кравец О.А. и др. Рак тела матки и саркомы матки. Практические рекомендации RUSSCO. Часть 1.2. Злокачественные опухоли 2024;14(3s2):165–88. Nechushkina V.M., Kolomiets L.A., Kravets O.A. and others. Cancer of the uterine body and uterine sarcomas. RUSSCO’s Practical Recommendations. Part 1.2. Zlokachestvennye opukholi = Malignant Tumors 2024;14(3s2):165–88.

5. Berek J.S., Matias-Guiu X., Creutzberg C. et al. Endometrial cancer staging subcommittee, FIGO Women’s Cancer Committee. FIGO staging of endometrial cancer: 2023. DOI: https://doi.org/10.1002/ijgo.14923

6. Krizova A., Clarke B.A., Bernardini M.Q. et al. Histologic artifacts in abdominal, vaginal, laparoscopic, and robotic hysterectomy specimens: a blinded, retrospective review. Am J Surg Pathol 2011;35:115–26. DOI: 10.1097/PAS.0b013e31820273dc

7. Malpica A., Euscher E.D., Hecht J.L. et al. Endometrial Carcinoma, Grossing and Processing Issues: Recommendations of the International Society of Gynecologic Pathologists. Int J Gynecol Path 2018;38:9–24. DOI: 10.1097/PGP.0000000000000552

8. Yamazawa K., Seki K., Matsui H., Sekiya S. Significance of perivascular lymphocytic infiltrates in endometrial carcinoma. Cancer 2001;91:1777–84. DOI: 10.1002/1097-0142(20010501)91:9<1777::aidcncr1196> 3.0.co;2-#

9. Wei S., Conner M.G., Zhang K. et al. Juxtatumoral stromal reactions in uterine endometrioid adenocarcinoma and their prognostic significance. Int J Gynecol Pathol 2010;29:562–7. DOI: 10.1097/PGP.0b013e3181e36321

10. Mannelqvist M., Stefansson I., Salvesen H.B., Akslen L.A. Importance of tumour cell invasion in blood and lymphatic vasculature among patients with endometrial carcinoma. Histopathology 2009;54:174–83. DOI: 10.1111/j.1365-2559.2008.03201.x

11. WWeber S.K., Sauerwald A., Polcher M. et al. Detection of lymphovascular invasion by D2–40 (podoplanin) immunoexpression in endometrial cancer. Int J Gynecol Cancer 2012;22:1442–8. DOI: 10.1097/IGC.0b013e318269139b

12. Visser N.C.M., Werner H.M.J., Krakstad C. et al. Type of vascular invasion in association with progress of endometrial cancer. APMIS 2017;125:1084–91. DOI: 10.1111/apm.12774

13. Alexander-Sefre F., Singh N., Ayhan A. et al. Detection of tumour lymphovascular space invasion using dual cytokeratin and CD31 immunohistochemistry. J Clin Pathol 2003;56:786–8. DOI: 10.1136/jcp.56.10.786

14. Alexander-Sefre F., Singh N., Ayhan A. et al. Clinical value of immunohistochemically detected lymphovascular invasion in endometrioid endometrial cancer. Gynecol Oncol 2004;92: 653–9. DOI: 10.1016/j.ygyno.2003.11.012

15. Kayraklioglu N., Katsakhyan L., Cohen P.A. et al. Perceptions of controversies and unresolved issues in the 2014 FIGO staging system for endometrial cancer: survey results from members of the International Society of Gynecological Pathologists and International Gynecologic Cancer Society. Int J Gynecol Pathol 2024;43:242–52. DOI: 10.1097/PGP.0000000000000977

16. Bosse T., Peters E.E., Creutzberg C.L. et al. Substantial lymphvascular space invasion is a significant risk factor for recurrence in endometrial cancer-a pooled analysis of PORTEC 1 and 2 trials. Eur J Cancer 2015;51(13):1742–50. DOI: 10.1016/j.ejca.2015.05.015

17. Fujimoto T., Nanjyo H., Fukuda J. et al. Endometrioid uterine cancer: histopathological risk factors of local and distant recurrence. Gynecol Oncol 2009;112:342–7. DOI: 10.1016/j.ygyno.2008.10.019

18. Han L., Chen Y., Zheng A. et al. Prognostic value of three-tiered scoring system for lymph-vascular space invasion in endometrial cancer: A systematic review and meta-analysis. Gynecol Oncol 2024;184:198–205. DOI: 10.1016/j.ygyno.2024.01.046

19. Tortorella L., Restaino S., Zannoni G.F. et al. Substantial lymph- vascular space invasion (LVSI) as predictor of distant relapse and poor prognosis in low-risk early-stage endometrial cancer. J Gynecol Oncol 2021;32(2):e11. DOI: 10.3802/jgo.2021.32.e11

20. Peters E.E.M., Leon-Castillo A., Hogdall E. et al. Substantial lymphovascular space invasion is an adverse prognostic factor in high-risk endometrial cancer. Int J Gynecol Pathol 2022;41: 227–34. DOI: 10.1097/PGP.0000000000000805

21. Peters E.E.M., Leon-Castillo A., Smit V. et al. Defining substantial lymphovascular space invasion in endometrial cancer. Int J Gynecol Pathol 2022;41:220–6. DOI: 10.1097/PGP.0000000000000806